Brain tumour recurrence: Brain single-photon emission computerized tomography, pet and proton magnetic resonance spectroscopy

Nuclear Medicine Communications

Volumn 29, Issue 8, 2008, Pages 730-735

  Palumbo, Barbara ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Brain tumours; PET; Proton magnetic resonance spectroscopy; Single photon emission computerized tomography

Indexed keywords

3' FLUOROTHYMIDINE F 18; CHOLINE C 11; FLUORODEOXYGLUCOSE F 18; GLUCEPTATE TC 99M; IODOPHENYLALANINE I 123; METHIONINE C 11; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; METIROSINE I 123; RADIOPHARMACEUTICAL AGENT; TETROFOSMIN TC 99M; THALLIUM 201; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT;

ACCURACY; BRAIN TUMOR; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; FOLLOW UP; HUMAN; NEUROIMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR RECURRENCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SCINTISCANNING;

BRAIN NEOPLASMS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 55249119757     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3283000049     Document Type: Review

References (32)

1. Vos MJ, Hoekstra OS, Barkhof F, Berkhof J, Heimans JJ, van Groeningen CJ, et al. Thallium-201 single-photon emission computed tomography as an early predictor of outcome in recurrent glioma. J Clin Oncol 2003; 21:3559-3565.
2. Benard F, Romsa J, Hustinx R. Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin Nucl Med 2003; 33:148-162.
3. Minn H. PET and SPECT in low-grade glioma. Eur J Radiol 2005; 56:171-178.
4. 201Tl SPET in the detection of recurrent brain tumours after radiation therapy. Nucl Med Commun 2002; 23:1183-1190.
5. 201Tl. Neuroradiology 2001; 43:1023-1030.
6. 18F-FDG PET using a dual-headed coincidence camera - a pilot study. Nucl Med Commun 1999; 20:411-417.
7. Serizawa T, Saeki N, Higuchi Y, Ono J, Matsuda S, Sato M, et al. Diagnostic value of thallium-201 chloride single-photon emission computerized tomography in differentiating tumour recurrence from radiation injury after gamma knife surgery for metastatic brain tumors. J Neurosurg 2005; 102 (Suppl):266-271.
8. Dierckx RA, Martin JJ, Dobbeleir A, Crols R, Neetens I, De Deyn PP. Sensitivity and specificity of thallium-201 single-photon emission tomography in the functional detection and differential diagnosis of brain tumours. Eur J Nucl Med 1994; 21:621-633.
9. 99mTc-MIBI SPET. Eur J Nucl Med Mol Imaging 2002; 29:1455-1461.
10. Langen KJ, Ziemons K, Kiwit JC, Herzog H, Kuwert T, Bock WJ, et al. 3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET. J Nucl Med 1997; 38:517-522.
11. Barai S, Rajkamal, Bandopadhayaya GP, Pant GS, Haloi AK, Malhotra A. Thallium-201 versus Tc99m-glucoheptonate SPECT for evaluation of recurrent brain tumours: a within-subject comparison with pathological correlation. J Clin Neurosci 2005; 12:27-31.
12. Kaplan WD, Takvorian T, Morris JH, Rumbaugh CL, Connelly BT, Atkins HL. Thallium-201 brain tumour imaging: a comparative study with pathological correlation. J Nucl Med 1987; 28:47-52.
13. 99mTc-MIBI, and 18F-fluorodeoxyglucose. J Neurooncol 2000; 46:63-70.
14. Barai S, Bandopadhayaya GP, Julka PK, Malhotra A, Bal CS, Dhanpathi H. Imaging using Tc99m-tetrofosmin for the detection of the recurrence of brain tumour: a comparative study with Tc99m-glucoheptonate. J Postgrad Med 2004; 50:89-93.
15. 99mTc-MIBI SPET. Q J Nucl Med 2002; 46:336-345.
16. Samnick S, Hellwig D, Bader JB, Romeike BF, Moringlane JR, Feiden W, Kirsch CM. Initial evaluation of the feasibility of single-photon emission tomography with p-(123 I)iodo-L-phenylalanine for routine brain tumour imaging. Nucl Med Commun 2002; 23:121-130.
17. 18F-FDG PET. Eur J Nucl Med Mol Imaging 2002; 29:176-182.
18. Van Laere K, Ceyssens S, Van Calenbergh F, de Groot T, Menten J, Flamen P, et al. Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value. Eur J Nucl Med Mol Imaging 2005; 32:39-51.
19. Ceyssens S, Van Laere K, de Groot T, Goffin J, Bormans G, Mortelmans L. [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence. AJNR Am J Neuroradiol 2006; 27:1432-1437.
20. Kim EE, Chung SK, Haynie TP, Kim CG, Cho BJ, Podoloff DA, et al. Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET. Radiographics 1992; 12:269-279.
21. Wang SX, Boethius J, Ericson K. FDG-PET on irradiated brain tumor: ten years’ summary. Acta Radiol 2006; 47:85-90.
22. Van Waarde A, Jager PL, Ishiwata K, Dierckx RA, Elsinga PH. Comparison of Sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation. J Nucl Med 2006; 47:150-154.
23. 18F]fluoro-ethyl)-1-thyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas. Neurosurgery 2005; 57:505-511.
24. 1H NMR spectroscopy at 3.0T in the differential diagnosis of recurrent or residual gliomas: a comparative study. J Neurooncol 2004; 70:49-58.
25. 1H-MRS) to assess glioma recurrence after radiotherapy. Q J Nucl Med Mol Imaging 2006; 50:88-93.
26. Fan G, Sun B, Wu Z, Guo Q, Guo Y. in vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases. Clin Radiol 2004; 59:77-85.
27. Tong Z, Yamaki T, Harada K, Houkin K. in vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard. Magn Reson Imaging 2004; 22:1017-1024.
28. Wald LL, Nelson SJ, Day MR, Noworolski SE, Henry RG, Huhn SL, et al. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J Neurosurg 1997; 87:525-534.
29. 1H NMR spectroscopic investigation. NMR Biomed 2005; 18:371-382.
30. Rock JP, Hearshen D, Scarpace L, Croteau D, Gutierrez J, Fischer JL, et al. Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis. Neurosurgery 2002; 51:912-919.
31. Ando K, Ishikura R, Nagami Y, Morikawa T, Takada Y, Ikeda J, et al. Usefulness of Cho/Cr ratio in proton MR spectroscopy for differentiating residual/recurrent glioma from non-neoplastic lesions. Nippon Igaku Hoshasen Gakkai Zasshi 2004; 64:121-126.
32. Chernov M, Hayashi M, Izawa M, Ochiai T, Usukura M, Abe K, et al. Differentiation of the radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases: importance of multi-voxel proton MRS. Minim Invasive Neurosurg 2005; 48:228-234.